Viagra (Sildenafil Citrate)

Viagra pillsAfter Viagra hit the market years ago, it generated a great deal of profit for its manufacturing company, Pfizer. The active ingredient in the branded Viagra is sildenafil which is known for its effectiveness in increasing the blood flow in the penile region that counteracts the symptoms of erectile dysfunction. After the advent of dominating the market as the only erectile dysfunction medicine approved by the FDA, it enjoyed years of profitable sale, with Pfizer having the exclusive patent right over Viagra.

Then came the generic version of Viagra in the form of Cialis which produces the same effects as Viagra but its active ingredient is derived from Tadalafil. Cialis provides a cheaper alternative for the management of the symptoms of impotence. However, competitions began to surface. Other generic forms of Viagra appeared using sildenafil as an active ingredient for the drugs.

Unipharm, for instance, has just gained the approval of the Health Ministry of Israeli to allow their generic version of Viagra called Tarim to be disposed in the open market under an at-risk launching of their product. Tarim is marketed as a cheapest Viagra form, which under an at-risk market, may open Unipharm under the risk of being sued for patent infringement by Pfizer which Viagra patent does not expire in Israeli until 2014. This means that Tarim may be sold in the market as the generic version of the patented brand of Viagra without any prejudice to the right of Pfizer to sue Unipharm if it chooses to.

Pharma Dynamics, a generic cardiovascular medicine manufacturer, will soon release its own generic Viagra called Dynafil and will hit the shelves in Iceland pharmacies sometime in May and in Europe in July this year. The study conducted by the company researchers aims to prove the link on the effectiveness of the management of impotence with an improvement of cardiovascular disease using Dynafil. The study was published in the International Journal of Urology where there are sufficient beliefs that Dynafil offers potential health benefits aside from being a drug for impotence.

The market growth of generic Viagra continues to grow as more researchers were conducted by pharmaceutical companies believing that the active ingredient in Viagra, sildenafil has the strong potential of becoming a treatment option for other medical conditions. Other drug companies are also venturing of concocting their own generic Viagra mainly because of its marketability for being a cheaper alternative to the branded Viagra. If there is something good about this competition, it is the fact that it lowers the costs of the treatment options of medication for erectile dysfunction.

The most common and widely marketed drugs for erectile dysfunction namely Cialis, Levitra, and Viagra have already lowered their product prices owing to a competitive market. Now that more generic Viagras have cropped in the market, impotent men will be pleased to have better and cheaper options for their medications. However, it is always prudent to keep in mind to be wary against counterfeit generic Viagra that is sold very cheap. The drop in price is an appealing feature of generic Viagra but it made the public vulnerable to counterfeit medicines that pose serious health risks.